Xetra
22.04.26 | 17:35
294,80 Euro
+0,58 % +1,70
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 294,65 | 295,25 | 22.04. | |
| 294,55 | 296,35 | 22.04. |
► 22.04.: | | | | | | |
| |
► 21.04.: | | | | | | | | | 17:30
► Aktueller AMGEN Börsenkurs + Xetra-Orderbuch
► 21.04.: | | | | | | | | | 17:30
► Aktueller AMGEN Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 303,70 | 50 | |||
| 303,60 | 50 | |||
| 303,55 | 50 | |||
| 296,95 | 2 | |||
| 296,85 | 2 | |||
| 296,75 | 2 | |||
| 296,70 | 2 | |||
| 295,15 | 50 | |||
| 295,10 | 28 | |||
| 295,05 | 50 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/amg.htm [/URL] | ||||
| 50 | 294,15 | |||
| 28 | 294,10 | |||
| 50 | 294,05 | |||
| 50 | 293,95 | |||
| 50 | 293,85 | |||
| 50 | 293,75 | |||
| 2 | 292,45 | |||
| 2 | 292,35 | |||
| 2 | 292,25 | |||
| 50 | 285,35 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 334 | 0,856 | 286 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 15:41:34 | 293,00 | 2 |
| 15:34:04 | 295,35 | 8 |
| 10:09:33 | 291,55 | 5 |
| 10:09:33 | 291,60 | 62 |
| 09:04:41 | 295,05 | 3 |
| Tagesumsatz Xetra | +1,70 +0,58 % | 88 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | AMGN recognizes the energy role of natural gas | 5 | MexicoNow | ||
| Mi | Maria Elvira Salazar makes significant purchases in Amgen, Boeing, and Cisco | 6 | Investing.com | ||
| Mi | Congressional Trading Report: Rep. Maria Elvira Salazar Bought Over $221K In Amgen Stock | 4 | Benzinga.com | ||
| AMGEN Aktie jetzt für 0€ handeln | |||||
| Di | AMGEN INC - Stabilität als strategische Chance | 8 | Maximilian Berger | ||
| Mo | What to Expect From Amgen's Next Quarterly Earnings Report | 12 | Barchart.com |
1 2 3 4 5 Weiter >>
324 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mi | GenScript Biotech Corporation: GenScript Leaders Named Entrepreneur Of The Year 2026 New Jersey Finalists | PR Newswire | PISCATAWAY, N.J., April 22, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced that CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the... ► Artikel lesen | |
| Mi | Morning Market Movers: Axe Compute, Inhibrx Biosciences, Huachen AI Parking Management Technology, 1-800-FLOWERS.COM See Big Swings | AFX News | OTTAWA (dpa-AFX) - At 9:00 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Mi | Degroof Petercam Initiates Medincell's Coverage with a "Buy" Recommendation | Business Wire | Degroof Petercam, a leading European investment bank with strong healthcare expertise, has initiated coverage of Medincell In a report entitled "Royalty flywheel approaching profitability", the... ► Artikel lesen | |
| Mi | Humacyte, Inc: Humacyte Appoints Jim Mercadante as Chief Commercial Officer | GlobeNewswire (Europe) | - Industry veteran with more than 25 years of experience will lead next phase of biotech company's commercial expansion - - Seasoned medtech commercial leader brings extensive field-specific success... ► Artikel lesen | |
| Mi | Sanofi: Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria | GlobeNewswire (Europe) | Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
Approval for children aged two to 11 years with... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AMGEN INC finden Sie auf Wallstreet Online.